Behrens Mary Taylor

Insider CIK 1309855 · SGNT Director · HMA Director

Track record PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Upgrade to Pro · $99/year Already Pro? Log in

Trades across companies

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
SGNT Sagent Pharmaceuticals, In	D To issuer deriv	2016-08-29	2016-08-31	760	$21.75	$16.5K	0	SEC↗
SGNT Sagent Pharmaceuticals, In	D To issuer deriv	2016-08-29	2016-08-31	1,860	$21.75	$40.5K	0	SEC↗
SGNT Sagent Pharmaceuticals, In	D To issuer deriv	2016-08-29	2016-08-31	1,381	$21.75	$30.0K	0	SEC↗
SGNT Sagent Pharmaceuticals, In	D To issuer deriv	2016-08-29	2016-08-31	6,379	$10.15	$64.7K	0	SEC↗
SGNT Sagent Pharmaceuticals, In	D To issuer deriv	2016-08-29	2016-08-31	691	$21.75	$15.0K	0	SEC↗
SGNT Sagent Pharmaceuticals, In	D To issuer deriv	2016-08-29	2016-08-31	8,556	$21.75	$186.1K	0	SEC↗
SGNT Sagent Pharmaceuticals, In	U Tender	2016-08-29	2016-08-31	7,097	$21.75	$154.4K	0	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise deriv	2016-02-25	2016-02-25	230	—	$0	691	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise deriv	2016-02-25	2016-02-25	460	—	$0	1,381	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise	2016-02-25	2016-02-25	460	—	$0	6,867	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise	2016-02-25	2016-02-25	230	—	$0	7,097	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise deriv	2016-02-22	2016-02-23	567	—	$0	0	SEC↗
SGNT Sagent Pharmaceuticals, In	A Award deriv	2016-02-22	2016-02-23	8,556	—	$0	8,556	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise	2016-02-22	2016-02-23	567	—	$0	6,407	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise deriv	2016-02-21	2016-02-23	760	—	$0	760	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise	2016-02-21	2016-02-23	760	—	$0	5,840	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise deriv	2016-02-18	2016-02-22	930	—	$0	1,860	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise	2016-02-18	2016-02-22	930	—	$0	5,080	SEC↗
SGNT Sagent Pharmaceuticals, In	A Award deriv	2015-04-09	2015-04-13	921	—	$0	921	SEC↗
SGNT Sagent Pharmaceuticals, In	A Award deriv	2015-02-25	2015-02-27	1,841	—	$0	1,841	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise deriv	2015-02-22	2015-02-24	567	—	$0	567	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise	2015-02-22	2015-02-24	567	—	$0	4,150	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise deriv	2015-02-21	2015-02-24	760	—	$0	1,520	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise	2015-02-21	2015-02-24	760	—	$0	3,583	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise deriv	2015-02-18	2015-02-20	930	—	$0	2,790	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise	2015-02-18	2015-02-20	930	—	$0	2,823	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise deriv	2014-02-22	2014-02-24	567	—	$0	1,134	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise	2014-02-22	2014-02-24	567	—	$0	1,893	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise deriv	2014-02-21	2014-02-24	759	—	$0	2,280	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise	2014-02-21	2014-02-24	759	—	$0	1,326	SEC↗
SGNT Sagent Pharmaceuticals, In	A Award deriv	2014-02-18	2014-02-19	3,720	—	$0	3,720	SEC↗
HMA HEALTH MANAGEMENT ASSOCIAT	D To issuer deriv	2014-01-27	2014-01-27	11,068	—	$0	0	SEC↗
HMA HEALTH MANAGEMENT ASSOCIAT	D To issuer deriv	2014-01-27	2014-01-27	4,233	—	$0	0	SEC↗
HMA HEALTH MANAGEMENT ASSOCIAT	A Award deriv	2014-01-01	2014-01-03	11,068	—	$0	11,068	SEC↗
HMA HEALTH MANAGEMENT ASSOCIAT	A Award deriv	2013-11-12	2013-11-13	4,233	—	$0	4,233	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise deriv	2013-02-22	2013-02-25	567	—	$0	1,701	SEC↗
SGNT Sagent Pharmaceuticals, In	M Exercise	2013-02-22	2013-02-25	567	—	$0	567	SEC↗
SGNT Sagent Pharmaceuticals, In	A Award deriv	2013-02-21	2013-02-25	3,039	—	$0	3,039	SEC↗
SGNT Sagent Pharmaceuticals, In	A Award deriv	2012-02-22	2012-02-24	2,268	—	$0	2,268	SEC↗